| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.08 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |